#USA #Northfield #Animal Health #Aurora Pharmaceutical #economic pressures

Aurora Pharmaceutical's Commitment to Animal Health

Amidst rising tariffs and economic pressures that are influencing many sectors, Aurora Pharmaceutical stands out for its decision to halt price increases on their products. As many companies in the animal health industry opt to raise prices in response to escalating costs for imported ingredients, Aurora has chosen a different path that prioritizes the needs of its customers—producers, ranchers, and pet owners who are coping with uncertain financial conditions.

Understanding Economic Pressures

On April 28, 2025, CEO Dr. Mike Strobel, who has deep roots in animal care as a lifelong veterinarian, confirmed the company’s decision to maintain prices at least until July 1. Dr. Strobel, who grew up on a cattle farm, is acutely aware of the financial challenges that both producers and pet owners are currently facing. "Our customers are the heartbeat of this industry," he said, emphasizing the importance of supporting those who care for animals daily.

Recent surveys highlight that nearly 30% of pet owners are postponing or forgoing necessary preventive veterinary care, including critical medications for heartworms and fleas due to rising costs. The agriculture sector is not exempt from similar struggles: tariffs on essential operational needs are forcing some farmers to make tough choices regarding livestock health. Aurora Pharmaceutical is making a conscious choice to absorb the increased costs for now, showing their determination to help the pet and livestock communities weather this economic storm.

Putting Customers First

Dr. Strobel expressed the company's philosophy succinctly: "This is not the time to make this kind of change. It's a time to be there for the people who care for animals every day." By opting against price increases, Aurora Pharmaceutical is resonating with those who need the most support right now. This decision aims to relieve some financial pressure from their customers during this demanding period, giving them the opportunity to continue providing essential care to their animals without added stress.

Despite acknowledging that future price adjustments may become necessary, Dr. Strobel reaffirmed their present commitment. "We know we may have to revisit this in the future. But today, the right decision is to prioritize our customers. We want to give them some breathing room in a difficult economy. They deserve that."

About Aurora Pharmaceutical

As a veterinarian-founded company based in Northfield, Minnesota, Aurora Pharmaceutical dedicates itself to offering high-quality animal health products that are both reliable and accessible. They cater to livestock producers, pet owners, and veterinary professionals across the United States, emphasizing their role in promoting health and well-being in animals.

In conclusion, Aurora Pharmaceutical’s decision to maintain stable pricing during these turbulent times demonstrates a commendable commitment to the welfare of animals and their caretakers. It highlights a compassionate approach towards business, rooted in an understanding of the industry's dynamics.

For more information about their products and philosophy, visit Aurora Pharmaceutical.